Compounds > silybin
Page last updated: 2024-08-23

silybin and Brain Neoplasms

silybin has been researched along with Brain Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elhag, R; Mazzio, EA; Soliman, KF1
Chakrabarti, M; Ray, SK2
Bosch-Barrera, J; Brunet, J; Cañete, N; Cuyàs, E; Haro, M; Izquierdo, A; Marruecos, J; Menendez, JA; Pedraza, S; Porta, R; Sais, E1
Choi, CH; Kim, KW; Kim, TH; Kim, YK; Kwon, CH; Woo, JS1
Alimoghaddam, K; Dizaji, MZ; Ghaffari, SH; Ghavamzadeh, A; Malehmir, M1

Other Studies

6 other study(ies) available for silybin and Brain Neoplasms

ArticleYear
The effect of silibinin in enhancing toxicity of temozolomide and etoposide in p53 and PTEN-mutated resistant glioma cell lines.
    Anticancer research, 2015, Volume: 35, Issue:3

    Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Genes, p53; Glioma; Humans; Inhibitor of Apoptosis Proteins; Mutation; PTEN Phosphohydrolase; Silybin; Silymarin; Survivin; Temozolomide

2015
Synergistic anti-tumor actions of luteolin and silibinin prevented cell migration and invasion and induced apoptosis in glioblastoma SNB19 cells and glioblastoma stem cells.
    Brain research, 2015, Dec-10, Volume: 1629

    Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Glioblastoma; Humans; Luteolin; Neoplasm Invasiveness; Neoplastic Stem Cells; Silybin; Silymarin

2015
Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo.
    Apoptosis : an international journal on programmed cell death, 2016, Volume: 21, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Brain Neoplasms; Carmustine; Caspase 8; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dacarbazine; Female; Glioblastoma; Humans; Luteolin; Mice; Mice, Nude; MicroRNAs; Signal Transduction; Silybin; Silymarin; Sirolimus; Temozolomide; Xenograft Model Antitumor Assays

2016
Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin.
    Oncotarget, 2016, May-31, Volume: 7, Issue:22

    Topics: Administration, Oral; Aged; Antineoplastic Agents, Phytogenic; Brain Edema; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Compassionate Use Trials; Dietary Supplements; Female; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Silybin; Silymarin; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

2016
Silibinin inhibits glioma cell proliferation via Ca2+/ROS/MAPK-dependent mechanism in vitro and glioma tumor growth in vivo.
    Neurochemical research, 2009, Volume: 34, Issue:8

    Topics: Antioxidants; Apoptosis; Blotting, Western; Brain Neoplasms; Calcium; Calcium Signaling; Caspase 3; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Enzyme Activation; Glioma; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Indicators and Reagents; Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Silybin; Silymarin

2009
Synergistic effects of arsenic trioxide and silibinin on apoptosis and invasion in human glioblastoma U87MG cell line.
    Neurochemical research, 2012, Volume: 37, Issue:2

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Brain Neoplasms; Cell Line, Tumor; Drug Synergism; Glioblastoma; Humans; Neoplasm Invasiveness; Oxides; Silybin; Silymarin

2012